Reckitt Benckiser Group PLC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RBGLY and other ETFs, options, and stocks.

About RBGLY

Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. 

CEO
Kris Licht
CEOKris Licht
Employees
51,460
Employees51,460
Headquarters
Slough, Berkshire
HeadquartersSlough, Berkshire
Founded
2007
Founded2007
Employees
51,460
Employees51,460

RBGLY Key Statistics

Market cap
43.28B
Market cap43.28B
Price-Earnings ratio
10.62
Price-Earnings ratio10.62
Dividend yield
3.83%
Dividend yield3.83%
Average volume
788.32K
Average volume788.32K
High today
$13.70
High today$13.70
Low today
$13.43
Low today$13.43
Open price
$13.60
Open price$13.60
Volume
34.51K
Volume34.51K
52 Week high
$17.80
52 Week high$17.80
52 Week low
$12.49
52 Week low$12.49

RBGLY News

TipRanks 2d
Reckitt Benckiser price target lowered to 5,460 GBp at Deutsche Bank

Deutsche Bank lowered the firm’s price target on Reckitt Benckiser (RBGLY) to 5,460 GBp from 5,500 GBp and keeps a Hold rating on the shares. Published first o...

Analyst ratings

56%

of 18 ratings
Buy
55.6%
Hold
44.4%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.